In brief
In a decisive move, the U.K. government announced that the previously instituted restrictions on the use of puberty blockers for minors will be maintained indefinitely. Health Secretary Wes Streeting stated that medical experts advised against the risk associated with prescribing these treatments, emphasizing the need for more extensive research before they can be safely administered to young people. The measures, initially temporary, now apply to England, Scotland, Wales, and Northern Ireland. The National Health Service had previously halted routine prescriptions for puberty blockers based on a comprehensive review by pediatrician Hilary Cass, which found significant gaps in the existing evidence supporting these medical interventions.
Britain has taken a cautious approach toward treating minors with gender dysphoria, determining that further research is necessary to avoid exposing vulnerable youth to potential harm from puberty blockers.
